HK Stock MarketDetailed Quotes

01772 GANFENGLITHIUM

Watchlist
  • 17.480
  • +0.480+2.82%
Not Open Jul 16 16:08 CST
35.26BMarket Cap14.89P/E (TTM)

GANFENGLITHIUM Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Turnover
-46.41%5.06B
-20.69%32.81B
-6.99%25.68B
26.47%18.11B
75.91%9.44B
274.63%41.37B
291.45%27.61B
255.80%14.32B
233.91%5.37B
101.20%11.04B
Operating income
-46.41%5.06B
-20.69%32.81B
-6.99%25.68B
26.47%18.11B
75.91%9.44B
274.63%41.37B
291.45%27.61B
255.80%14.32B
233.91%5.37B
101.20%11.04B
Cost of sales
----
-34.26%-28.2B
----
-146.90%-13.98B
----
-214.18%-21.01B
----
-116.17%-5.66B
----
-54.52%-6.69B
Operating expenses
19.78%-4.74B
-34.26%-28.2B
-74.24%-21.21B
-146.90%-13.98B
-230.59%-5.92B
-214.18%-21.01B
-167.74%-12.17B
-116.17%-5.66B
-61.64%-1.79B
-54.52%-6.69B
Gross profit
-91.12%313.03M
-77.37%4.61B
-71.03%4.47B
-52.30%4.13B
-1.48%3.52B
367.39%20.36B
515.75%15.44B
516.08%8.66B
615.33%3.58B
275.08%4.36B
Selling expenses
-42.02%-42.49M
-51.19%-177.44M
-46.13%-102.14M
-69.27%-68.73M
-158.47%-29.92M
-90.45%-117.36M
-84.60%-69.89M
-69.74%-40.6M
8.23%-11.57M
-27.82%-61.62M
Administrative expenses
-102.27%-304.85M
-16.78%-2.34B
-28.31%-654.98M
-16.51%-1.06B
31.23%-150.72M
-137.96%-2B
-79.88%-510.48M
-332.53%-912.27M
-577.20%-219.16M
-155.94%-840.34M
Research and development expenses
44.67%-216.84M
----
1.13%-941.62M
----
-84.99%-391.93M
----
-373.80%-952.43M
----
-477.87%-211.86M
----
Profit from asset sales
-81.59%-24.67K
----
-65.30%1.39M
----
---13.59K
----
1,776.76%3.99M
----
----
----
Revaluation surplus
-274.78%-268.86M
----
24.76%650.52M
----
-67.56%153.83M
----
-47.53%521.44M
----
187.17%474.21M
----
-Changes in the fair value of other assets
-274.78%-268.86M
----
24.76%650.52M
----
-67.56%153.83M
----
-47.53%521.44M
----
187.17%474.21M
----
Impairment and provision
91.88%-97.62M
----
-2,471.08%-1.01B
----
-1,222,994.39%-1.2B
----
-221.98%-39.29M
----
-22.79%-98.32K
----
-Other impairment is provision
91.88%-97.62M
----
-2,471.08%-1.01B
----
-1,222,994.39%-1.2B
----
-221.98%-39.29M
----
-22.79%-98.32K
----
Operating interest expense
----
----
----
-75.95%-342.58M
----
----
----
-36.24%-194.71M
----
0.39%-264.86M
Special items of operating profit
-42.92%345.73M
2.80%1.05B
47.26%4.31B
318.50%1.36B
29.45%605.69M
-59.32%1.02B
5,744.98%2.93B
-197.39%-620.54M
3,340.25%467.89M
319.46%2.52B
Operating profit
-111.65%-290.34M
-83.66%3.15B
-61.01%6.67B
-41.78%4.01B
-38.31%2.49B
237.56%19.27B
475.71%17.11B
313.87%6.89B
591.53%4.04B
409.87%5.71B
Financing cost
-50.48%-209.41M
-92.55%-784.31M
-477.51%-379.61M
----
-251.25%-139.16M
---407.33M
167.67%100.56M
----
23.43%-39.62M
----
Share of profits of associates
----
-44.83%923.76M
----
0.30%620.29M
----
2,401.34%1.67B
----
1,582.72%618.43M
----
364.55%66.94M
Share of profit from joint venture company
----
-10.47%2.01B
----
78.07%1.62B
----
42,985.18%2.24B
----
1,536.91%909.21M
----
-115.61%-5.22M
Special items of earning before tax
83.37%-35.12K
----
78.19%44.6M
----
-100.66%-211.19K
----
451.86%25.03M
----
98,424.68%31.87M
----
Earning before tax
-121.23%-499.78M
-76.76%5.29B
-63.24%6.34B
-25.74%6.25B
-41.64%2.35B
294.71%22.78B
512.00%17.23B
413.83%8.42B
657.30%4.03B
411.65%5.77B
Tax
49.48%-95.87M
70.52%-683.47M
79.70%-455.97M
64.57%-377.64M
59.91%-189.78M
-549.34%-2.32B
-718.81%-2.25B
-502.34%-1.07B
-1,115.48%-473.42M
-460.54%-357M
After-tax profit from continuing operations
-127.53%-595.65M
-77.46%4.61B
-60.77%5.88B
-20.11%5.87B
-39.21%2.16B
277.92%20.46B
489.68%14.99B
403.11%7.35B
621.15%3.56B
408.73%5.41B
Earning after tax
-127.53%-595.65M
-77.46%4.61B
-60.77%5.88B
-20.11%5.87B
-39.21%2.16B
277.92%20.46B
489.68%14.99B
403.11%7.35B
621.15%3.56B
408.73%5.41B
Minority profit
32.62%-156.75M
-765.08%-371.56M
-167.78%-130.35M
-103.55%-3.43M
-765.72%-232.63M
-122.83%-42.95M
179.56%192.32M
110.08%96.74M
98.93%34.94M
383.36%188.14M
Profit attributable to shareholders
-118.31%-438.9M
-75.70%4.98B
-59.38%6.01B
-19.00%5.88B
-32.01%2.4B
292.35%20.5B
498.31%14.79B
412.65%7.25B
640.41%3.53B
409.69%5.23B
Basic earnings per share
-118.49%-0.22
-75.74%2.47
-59.46%2.98
-18.89%2.92
-32.00%1.19
281.27%10.18
315.25%7.35
386.49%3.6
386.11%1.75
237.97%2.67
Diluted earnings per share
-118.49%-0.22
-75.71%2.47
-59.35%2.98
-18.89%2.92
-32.00%1.19
282.33%10.17
314.12%7.33
386.49%3.6
386.11%1.75
236.71%2.66
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
Audit Opinions
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
Auditor
--
Ernst & Young (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Turnover -46.41%5.06B-20.69%32.81B-6.99%25.68B26.47%18.11B75.91%9.44B274.63%41.37B291.45%27.61B255.80%14.32B233.91%5.37B101.20%11.04B
Operating income -46.41%5.06B-20.69%32.81B-6.99%25.68B26.47%18.11B75.91%9.44B274.63%41.37B291.45%27.61B255.80%14.32B233.91%5.37B101.20%11.04B
Cost of sales -----34.26%-28.2B-----146.90%-13.98B-----214.18%-21.01B-----116.17%-5.66B-----54.52%-6.69B
Operating expenses 19.78%-4.74B-34.26%-28.2B-74.24%-21.21B-146.90%-13.98B-230.59%-5.92B-214.18%-21.01B-167.74%-12.17B-116.17%-5.66B-61.64%-1.79B-54.52%-6.69B
Gross profit -91.12%313.03M-77.37%4.61B-71.03%4.47B-52.30%4.13B-1.48%3.52B367.39%20.36B515.75%15.44B516.08%8.66B615.33%3.58B275.08%4.36B
Selling expenses -42.02%-42.49M-51.19%-177.44M-46.13%-102.14M-69.27%-68.73M-158.47%-29.92M-90.45%-117.36M-84.60%-69.89M-69.74%-40.6M8.23%-11.57M-27.82%-61.62M
Administrative expenses -102.27%-304.85M-16.78%-2.34B-28.31%-654.98M-16.51%-1.06B31.23%-150.72M-137.96%-2B-79.88%-510.48M-332.53%-912.27M-577.20%-219.16M-155.94%-840.34M
Research and development expenses 44.67%-216.84M----1.13%-941.62M-----84.99%-391.93M-----373.80%-952.43M-----477.87%-211.86M----
Profit from asset sales -81.59%-24.67K-----65.30%1.39M-------13.59K----1,776.76%3.99M------------
Revaluation surplus -274.78%-268.86M----24.76%650.52M-----67.56%153.83M-----47.53%521.44M----187.17%474.21M----
-Changes in the fair value of other assets -274.78%-268.86M----24.76%650.52M-----67.56%153.83M-----47.53%521.44M----187.17%474.21M----
Impairment and provision 91.88%-97.62M-----2,471.08%-1.01B-----1,222,994.39%-1.2B-----221.98%-39.29M-----22.79%-98.32K----
-Other impairment is provision 91.88%-97.62M-----2,471.08%-1.01B-----1,222,994.39%-1.2B-----221.98%-39.29M-----22.79%-98.32K----
Operating interest expense -------------75.95%-342.58M-------------36.24%-194.71M----0.39%-264.86M
Special items of operating profit -42.92%345.73M2.80%1.05B47.26%4.31B318.50%1.36B29.45%605.69M-59.32%1.02B5,744.98%2.93B-197.39%-620.54M3,340.25%467.89M319.46%2.52B
Operating profit -111.65%-290.34M-83.66%3.15B-61.01%6.67B-41.78%4.01B-38.31%2.49B237.56%19.27B475.71%17.11B313.87%6.89B591.53%4.04B409.87%5.71B
Financing cost -50.48%-209.41M-92.55%-784.31M-477.51%-379.61M-----251.25%-139.16M---407.33M167.67%100.56M----23.43%-39.62M----
Share of profits of associates -----44.83%923.76M----0.30%620.29M----2,401.34%1.67B----1,582.72%618.43M----364.55%66.94M
Share of profit from joint venture company -----10.47%2.01B----78.07%1.62B----42,985.18%2.24B----1,536.91%909.21M-----115.61%-5.22M
Special items of earning before tax 83.37%-35.12K----78.19%44.6M-----100.66%-211.19K----451.86%25.03M----98,424.68%31.87M----
Earning before tax -121.23%-499.78M-76.76%5.29B-63.24%6.34B-25.74%6.25B-41.64%2.35B294.71%22.78B512.00%17.23B413.83%8.42B657.30%4.03B411.65%5.77B
Tax 49.48%-95.87M70.52%-683.47M79.70%-455.97M64.57%-377.64M59.91%-189.78M-549.34%-2.32B-718.81%-2.25B-502.34%-1.07B-1,115.48%-473.42M-460.54%-357M
After-tax profit from continuing operations -127.53%-595.65M-77.46%4.61B-60.77%5.88B-20.11%5.87B-39.21%2.16B277.92%20.46B489.68%14.99B403.11%7.35B621.15%3.56B408.73%5.41B
Earning after tax -127.53%-595.65M-77.46%4.61B-60.77%5.88B-20.11%5.87B-39.21%2.16B277.92%20.46B489.68%14.99B403.11%7.35B621.15%3.56B408.73%5.41B
Minority profit 32.62%-156.75M-765.08%-371.56M-167.78%-130.35M-103.55%-3.43M-765.72%-232.63M-122.83%-42.95M179.56%192.32M110.08%96.74M98.93%34.94M383.36%188.14M
Profit attributable to shareholders -118.31%-438.9M-75.70%4.98B-59.38%6.01B-19.00%5.88B-32.01%2.4B292.35%20.5B498.31%14.79B412.65%7.25B640.41%3.53B409.69%5.23B
Basic earnings per share -118.49%-0.22-75.74%2.47-59.46%2.98-18.89%2.92-32.00%1.19281.27%10.18315.25%7.35386.49%3.6386.11%1.75237.97%2.67
Diluted earnings per share -118.49%-0.22-75.71%2.47-59.35%2.98-18.89%2.92-32.00%1.19282.33%10.17314.12%7.33386.49%3.6386.11%1.75236.71%2.66
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IAS
Audit Opinions --Unqualified Opinion------Unqualified Opinion------Unqualified Opinion
Auditor --Ernst & Young (Special General Partnership)------Ernst & Young (Special General Partnership)------Ernst & Young (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg